Cover Image

ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation

Accumulating evidence has highlighted that sirtuin-6 (SIRT6) plays an important role in hepatic gluconeogenesis and lipogenesis. We aim to investigate the underlying mechanisms and pharmacological interventions of SIRT6 on hepatic steatosis treatment. Herein, our results showed that atractylenolide...

Full description

Saved in:

Bibliographic Details
Main Authors:	Danli Kong (Author), Zhenhua Mai (Author), Yongze Chen (Author), Ling Luo (Author), Hao Liu (Author), Le Zhao (Author), Ruixian Huang (Author), Shuang Wang (Author), Rong Chen (Author), Hao Zhou (Author), Hao Chen (Author), Jingjing Zhang (Author), Haibing Yu (Author), Yuanlin Ding (Author)
Format:	Book
Published:	MDPI AG, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between systemic immune-inflammatory index and diabetes mellitus: mediation analysis involving obesity indicators in the NHANES
by: Yongze Chen, et al.
Published: (2024)

Genetically predicted lifestyle factors, socioeconomic status and risk of coronary artery disease in individuals with diabetes: a Mendelian randomization study
by: Zhenhua Mai, et al.
Published: (2023)

Bayesian network analysis of factors influencing type 2 diabetes, coronary heart disease, and their comorbidities
by: Danli Kong, et al.
Published: (2024)

Role of remnant cholesterol in the relationship between physical activity and diabetes mellitus: an intermediary analysis
by: Zihua Yang, et al.
Published: (2024)

SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation
by: Mingzhu Jiang, et al.
Published: (2021)

Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases
by: Haowen Xu, et al.
Published: (2023)

Indole-3-Carboxaldehyde Alleviates LPS-Induced Intestinal Inflammation by Inhibiting ROS Production and NLRP3 Inflammasome Activation
by: Ji Cao, et al.
Published: (2024)

IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome
by: Yun Ge, et al.
Published: (2021)

Shugan Hewei Decoction Alleviates Cecum Mucosal Injury and Improves Depressive- and Anxiety-Like Behaviors in Chronic Stress Model Rats by Regulating Cecal Microbiota and Inhibiting NLRP3 Inflammasome
by: Yingying Yue, et al.
Published: (2021)

α-Cyperone Confers Antidepressant-Like Effects in Mice via Neuroplasticity Enhancement by SIRT3/ROS Mediated NLRP3 Inflammasome Deactivation
by: Baomei Xia, et al.
Published: (2020)

Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway
by: Chen H, et al.
Published: (2019)

Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
by: Ting-Chen Chang, et al.
Published: (2019)

Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway
by: Jie Yang, et al.
Published: (2022)

Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
by: Shan M, et al.
Published: (2024)

Involvement of HO-1 and Autophagy in the Protective Effect of Magnolol in Hepatic Steatosis-Induced NLRP3 Inflammasome Activation In Vivo and In Vitro
by: Ni-Chun Kuo, et al.
Published: (2020)

NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
by: Pengfei Chen, et al.
Published: (2024)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023)

Activation of Platelet NLRP3 Inflammasome in Crohn's Disease
by: Ge Zhang, et al.
Published: (2021)

Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway
by: Meng Wang, et al.
Published: (2019)

The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
by: Ruixue Kong, et al.
Published: (2022)

Wuwei Kushen Changrong capsule alleviates DSS-induced colitis in mice via inhibition of NLRP3 inflammasome and STAT3 pathway
by: Mingjun Chen, et al.
Published: (2024)

Aucubin Alleviates Intervertebral Disc Degeneration by Repressing NF-κB-NLRP3 Inflammasome Activation in Endplate Chondrocytes
by: Zou K, et al.
Published: (2023)

Effect of NLRP3 inflammasome induced astrocyte phenotype alteration in morphine tolerance
by: Zhenyu Yuan, et al.
Published: (2024)

Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
by: Qiang Su, et al.
Published: (2021)

Aspirin alleviates endothelial gap junction dysfunction through inhibition of NLRP3 inflammasome activation in LPS-induced vascular injury
by: Xing Zhou, et al.
Published: (2019)

Loratadine Alleviates Advanced Glycation End Product-Induced Activation of NLRP3 Inflammasome in Human Chondrocytes
by: Gao F, et al.
Published: (2020)

Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
by: Qi Lv, et al.
Published: (2021)

Targeting NLRP3 Inflammasome Alleviates Synovitis by Reducing Pyroptosis in Rats with Experimental Temporomandibular Joint Osteoarthritis
by: Yinzi Xin, et al.
Published: (2022)

Characterization of the Atl-mediated staphylococcal internalization mechanism
by: Tim Schlesier, et al.
Published: (2020)

Bisdemethoxycurcumin Alleviates Dextran Sodium Sulfate-Induced Colitis via Inhibiting NLRP3 Inflammasome Activation and Modulating the Gut Microbiota in Mice
by: Jingfei Zhang, et al.
Published: (2022)

Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
by: Mei-Zi Wang, et al.
Published: (2022)

Aloperine Ameliorates Acetaminophen-Induced Acute Liver Injury through HMGB1/TLR4/NF-κB and NLRP3/Inflammasome Pathway
by: Hui Chen, et al.
Published: (2024)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011)

Canagliflozin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Inhibiting NF-κB Signaling and Upregulating Bif-1
by: Yaoyun Niu, et al.
Published: (2022)

Corilagin alleviates intestinal ischemia/reperfusion-induced intestinal and lung injury in mice via inhibiting NLRP3 inflammasome activation and pyroptosis
by: Wenlian Li, et al.
Published: (2022)

The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis
by: Xiao-Nan Zhang, et al.
Published: (2022)

Autophagy Induced by Micheliolide Alleviates Acute Irradiation-Induced Intestinal Injury via Inhibition of the NLRP3 Inflammasome
by: Dong-ming Wu, et al.
Published: (2022)